Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells

Breast cancer is the leading cause of cancer-related mortality among females worldwide, and therefore the development of new therapeutic approaches is still needed. Rosemary (Rosmarinus officinalis L.) extract possesses antitumor properties against tumor cells from several organs, including breast. However, in order to apply it as a complementary therapeutic agent in breast cancer, more information is needed regarding the sensitivity of the different breast tumor subtypes and its effect in combination with the currently used chemotherapy. Here, we analyzed the antitumor activities of a supercritical fluid rosemary extract (SFRE) in different breast cancer cells, and used a genomic approach to explore its effect on the modulation of ER-α and HER2 signaling pathways, the most important mitogen pathways related to breast cancer progression. We found that SFRE exerts antitumor activity against breast cancer cells from different tumor subtypes and the downregulation of ER-α and HER2 receptors by SFRE might be involved in its antitumor effect against estrogen-dependent (ER+) and HER2 overexpressing (HER2+) breast cancer subtypes. Moreover, SFRE significantly enhanced the effect of breast cancer chemotherapy (tamoxifen, trastuzumab, and paclitaxel). Overall, our results support the potential utility of SFRE as a complementary approach in breast cancer therapy. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Saved in:
Bibliographic Details
Main Authors: González-Vallinas, Margarita, Molina, Susana, Vicente, G., Sánchez-Martínez, Ruth, Vargas, Teodoro, García-Risco, Mónica R., Fornari, Tiziana, Reglero, Guillermo, Ramírez de Molina, Ana
Other Authors: Ministerio de Ciencia e Innovación (España)
Format: artículo biblioteca
Published: Wiley-VCH 2014
Subjects:Estrogen receptor alpha, Human epidermal growth factor receptor-2, Paclitaxel, Rosemary, Breast cancer,
Online Access:http://hdl.handle.net/10261/100154
http://dx.doi.org/10.13039/501100004837
http://dx.doi.org/10.13039/501100000780
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-cial-es-10261-100154
record_format koha
spelling dig-cial-es-10261-1001542019-10-14T07:28:03Z Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells González-Vallinas, Margarita Molina, Susana Vicente, G. Sánchez-Martínez, Ruth Vargas, Teodoro García-Risco, Mónica R. Fornari, Tiziana Reglero, Guillermo Ramírez de Molina, Ana Ministerio de Ciencia e Innovación (España) European Commission Estrogen receptor alpha Human epidermal growth factor receptor-2 Paclitaxel Rosemary Breast cancer Breast cancer is the leading cause of cancer-related mortality among females worldwide, and therefore the development of new therapeutic approaches is still needed. Rosemary (Rosmarinus officinalis L.) extract possesses antitumor properties against tumor cells from several organs, including breast. However, in order to apply it as a complementary therapeutic agent in breast cancer, more information is needed regarding the sensitivity of the different breast tumor subtypes and its effect in combination with the currently used chemotherapy. Here, we analyzed the antitumor activities of a supercritical fluid rosemary extract (SFRE) in different breast cancer cells, and used a genomic approach to explore its effect on the modulation of ER-α and HER2 signaling pathways, the most important mitogen pathways related to breast cancer progression. We found that SFRE exerts antitumor activity against breast cancer cells from different tumor subtypes and the downregulation of ER-α and HER2 receptors by SFRE might be involved in its antitumor effect against estrogen-dependent (ER+) and HER2 overexpressing (HER2+) breast cancer subtypes. Moreover, SFRE significantly enhanced the effect of breast cancer chemotherapy (tamoxifen, trastuzumab, and paclitaxel). Overall, our results support the potential utility of SFRE as a complementary approach in breast cancer therapy. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. Funded by: Spanish Ministry of Science and Innovation. Grant Numbers: I+D+i AGL2010-21565, 2008-03734, IPT-2011-1248-060000 and European Union Structural Funds. Peer Reviewed 2014-07-18T10:34:14Z 2014-07-18T10:34:14Z 2014 2014-07-18T10:34:14Z artículo http://purl.org/coar/resource_type/c_6501 doi: 10.1002/elps.201400011 e-issn: 1522-2683 issn: 0173-0835 Electrophoresis 35(11): 1719-1727 (2014) http://hdl.handle.net/10261/100154 10.1002/elps.201400011 http://dx.doi.org/10.13039/501100004837 http://dx.doi.org/10.13039/501100000780 Sí none Wiley-VCH
institution CIAL ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-cial-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del CIAL España
topic Estrogen receptor alpha
Human epidermal growth factor receptor-2
Paclitaxel
Rosemary
Breast cancer
Estrogen receptor alpha
Human epidermal growth factor receptor-2
Paclitaxel
Rosemary
Breast cancer
spellingShingle Estrogen receptor alpha
Human epidermal growth factor receptor-2
Paclitaxel
Rosemary
Breast cancer
Estrogen receptor alpha
Human epidermal growth factor receptor-2
Paclitaxel
Rosemary
Breast cancer
González-Vallinas, Margarita
Molina, Susana
Vicente, G.
Sánchez-Martínez, Ruth
Vargas, Teodoro
García-Risco, Mónica R.
Fornari, Tiziana
Reglero, Guillermo
Ramírez de Molina, Ana
Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
description Breast cancer is the leading cause of cancer-related mortality among females worldwide, and therefore the development of new therapeutic approaches is still needed. Rosemary (Rosmarinus officinalis L.) extract possesses antitumor properties against tumor cells from several organs, including breast. However, in order to apply it as a complementary therapeutic agent in breast cancer, more information is needed regarding the sensitivity of the different breast tumor subtypes and its effect in combination with the currently used chemotherapy. Here, we analyzed the antitumor activities of a supercritical fluid rosemary extract (SFRE) in different breast cancer cells, and used a genomic approach to explore its effect on the modulation of ER-α and HER2 signaling pathways, the most important mitogen pathways related to breast cancer progression. We found that SFRE exerts antitumor activity against breast cancer cells from different tumor subtypes and the downregulation of ER-α and HER2 receptors by SFRE might be involved in its antitumor effect against estrogen-dependent (ER+) and HER2 overexpressing (HER2+) breast cancer subtypes. Moreover, SFRE significantly enhanced the effect of breast cancer chemotherapy (tamoxifen, trastuzumab, and paclitaxel). Overall, our results support the potential utility of SFRE as a complementary approach in breast cancer therapy. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
author2 Ministerio de Ciencia e Innovación (España)
author_facet Ministerio de Ciencia e Innovación (España)
González-Vallinas, Margarita
Molina, Susana
Vicente, G.
Sánchez-Martínez, Ruth
Vargas, Teodoro
García-Risco, Mónica R.
Fornari, Tiziana
Reglero, Guillermo
Ramírez de Molina, Ana
format artículo
topic_facet Estrogen receptor alpha
Human epidermal growth factor receptor-2
Paclitaxel
Rosemary
Breast cancer
author González-Vallinas, Margarita
Molina, Susana
Vicente, G.
Sánchez-Martínez, Ruth
Vargas, Teodoro
García-Risco, Mónica R.
Fornari, Tiziana
Reglero, Guillermo
Ramírez de Molina, Ana
author_sort González-Vallinas, Margarita
title Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
title_short Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
title_full Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
title_fullStr Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
title_full_unstemmed Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
title_sort modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells
publisher Wiley-VCH
publishDate 2014
url http://hdl.handle.net/10261/100154
http://dx.doi.org/10.13039/501100004837
http://dx.doi.org/10.13039/501100000780
work_keys_str_mv AT gonzalezvallinasmargarita modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT molinasusana modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT vicenteg modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT sanchezmartinezruth modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT vargasteodoro modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT garciariscomonicar modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT fornaritiziana modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT regleroguillermo modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
AT ramirezdemolinaana modulationofestrogenandepidermalgrowthfactorreceptorsbyrosemaryextractinbreastcancercells
_version_ 1777671142490767360